Jin-fang Jiang

Department Of Pathology And Key Laboratory Of Xinjiang Endemic And Ethnic Diseases
Shihezi, 832002, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Retraction Note: Overexpression of MAP3K3 promotes tumour growth through activation of the NF-κB signalling pathway in ovarian carcinoma.

Retraction Note: Overexpression of MAP3K3 promotes tumour growth through activation of the NF-κB signalling pathway in ovarian carcinoma.

Journal: Scientific reports
Published: September 23, 2025

Expressions and Prognostic Values of Notch3 and DLL4 in Human Breast Cancer.

Expressions and Prognostic Values of Notch3 and DLL4 in Human Breast Cancer.

Journal: Technology in cancer research & treatment
Published: February 06, 2023

Low-Grade Chondrosarcoma In The Sellar Area: Case Report And Literature Review.

Low-Grade Chondrosarcoma In The Sellar Area: Case Report And Literature Review.

Journal: OncoTargets and therapy
Published: July 07, 2019

Pure squamous cell carcinoma of the gallbladder locally invading the liver and abdominal cavity: A case report and review of the literature.

Pure squamous cell carcinoma of the gallbladder locally invading the liver and abdominal cavity: A case report and review of the literature.

Journal: World journal of clinical cases
Published: June 19, 2019

Overexpression of MAP3K3 promotes tumour growth through activation of the NF-κB signalling pathway in ovarian carcinoma.

Overexpression of MAP3K3 promotes tumour growth through activation of the NF-κB signalling pathway in ovarian carcinoma.

Journal: Scientific reports
Published: November 09, 2018

PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma.

PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma.

Journal: Journal of translational medicine
Published: December 17, 2015

Targeting oncogenic PLCE1 by miR-145 impairs tumor proliferation and metastasis of esophageal squamous cell carcinoma.

Targeting oncogenic PLCE1 by miR-145 impairs tumor proliferation and metastasis of esophageal squamous cell carcinoma.

Journal: Oncotarget
Published: October 23, 2015

Tumor necrosis factor-α gene 308G/A polymorphism is not associated with esophageal squamous cell carcinoma risk in Kazakh patients.

Tumor necrosis factor-α gene 308G/A polymorphism is not associated with esophageal squamous cell carcinoma risk in Kazakh patients.

Journal: International journal of clinical and experimental pathology
Published: May 31, 2015

SLC39A6: a potential target for diagnosis and therapy of esophageal carcinoma.

SLC39A6: a potential target for diagnosis and therapy of esophageal carcinoma.

Journal: Journal of translational medicine
Published: January 08, 2015

Prognostic value of PLCE1 expression in upper gastrointestinal cancer: a systematic review and meta-analysis.

Prognostic value of PLCE1 expression in upper gastrointestinal cancer: a systematic review and meta-analysis.

Journal: Asian Pacific journal of cancer prevention : APJCP
Published: December 19, 2014

BRCA1 gene exon 11 mutations in Uighur and Han women with early-onset sporadic breast cancer in the northwest region of China.

BRCA1 gene exon 11 mutations in Uighur and Han women with early-onset sporadic breast cancer in the northwest region of China.

Journal: Asian Pacific journal of cancer prevention : APJCP
Published: June 28, 2014

The correlation between morphology and the expression of TGF-β signaling pathway proteins and epithelial-mesenchymal transition-related proteins in synovial sarcomas.

The correlation between morphology and the expression of TGF-β signaling pathway proteins and epithelial-mesenchymal transition-related proteins in synovial sarcomas.

Journal: International journal of clinical and experimental pathology
Published: October 06, 2013
Showing 1-12 of 13

Last Updated: 09/26/2026